ZA978019B - Gene therapy for congestive heart failure - Google Patents

Gene therapy for congestive heart failure

Info

Publication number
ZA978019B
ZA978019B ZA978019A ZA978019A ZA978019B ZA 978019 B ZA978019 B ZA 978019B ZA 978019 A ZA978019 A ZA 978019A ZA 978019 A ZA978019 A ZA 978019A ZA 978019 B ZA978019 B ZA 978019B
Authority
ZA
South Africa
Prior art keywords
gene therapy
heart failure
congestive heart
congestive
therapy
Prior art date
Application number
ZA978019A
Inventor
H Kirk Hammond
Paul A Insel
Peipei Ping
Steven R Post
Meihau Gao
Original Assignee
Univ California
Collateral Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Collateral Therapeutics filed Critical Univ California
Publication of ZA978019B publication Critical patent/ZA978019B/en

Links

ZA978019A 1996-09-05 1997-09-05 Gene therapy for congestive heart failure ZA978019B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70866196A 1996-09-05 1996-09-05

Publications (1)

Publication Number Publication Date
ZA978019B true ZA978019B (en) 1998-11-11

Family

ID=24846697

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978019A ZA978019B (en) 1996-09-05 1997-09-05 Gene therapy for congestive heart failure

Country Status (2)

Country Link
CA (1) CA2718347A1 (en)
ZA (1) ZA978019B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019009113A2 (en) * 2016-11-04 2019-07-16 Baxalta GmbH adeno-associated virus formulations

Also Published As

Publication number Publication date
CA2718347A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
IL138063A0 (en) Controlling congestive heart failure
GB9622500D0 (en) Therapeutic gene
EP1180040A4 (en) Methods for treating congestive heart failure
AU2552795A (en) Safe vectors for gene therapy
ZA961587B (en) Gene transfer-mediated angiogenesis therapy
HK1008979A1 (en) Gene transfer-mediated angiogenesis therapy
AU6558098A (en) Intracardiac defibrillation system
EP0879279A4 (en) Diabetes therapy
AU3737297A (en) Bacteriophage-mediated gene therapy
AUPO833497A0 (en) Improved heart pacemaker
HUP0103252A3 (en) Gene therapy method
GB9700939D0 (en) Therapy
HUP0104046A3 (en) Adenovirus-mediated gene therapy
AU4401297A (en) Improved retroviral vectors for gene therapy
ZA959846B (en) Enzyme prodrug therapy
EP1021217A4 (en) Drive system for controlling cardiac compression
ZA978019B (en) Gene therapy for congestive heart failure
HU9801894D0 (en) Antiarrythmic agent for treating congestive heart failure
AU2492297A (en) Method for treating congestive heart failure
GB2333527B (en) Therapeutic gene
ZA996625B (en) Treatment of congestive heart failure.
GB9418696D0 (en) Gene therapy
AU8617498A (en) Improved heart pacemaker
GB9605476D0 (en) HIV gene therapy
GB9520433D0 (en) Gene therapy